Comparative molecular docking studies of lupeol and lupenone isolated from Pueraria lobata that inhibits BACE1: Probable remedies for Alzheimer's disease
Author(s) -
Prashamsa Koirala,
Su Hui Seong,
Hyun Ah Jung,
Jae Sue Choi
Publication year - 2017
Publication title -
asian pacific journal of tropical medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.491
H-Index - 52
ISSN - 1995-7645
DOI - 10.1016/j.apjtm.2017.10.018
Subject(s) - lupeol , chemistry , ic50 , triterpene , docking (animal) , stereochemistry , enzyme , pueraria , biochemistry , in vitro , medicine , alternative medicine , nursing , pathology
To discover lead lupane triterpenoid's potential isolated from Pueraria lobata roots against β-site amyloid precursor protein cleaving enzyme 1 (BACE1), which serve as a rate limiting step in amyloid beta (Aβ) production altering the course of Alzheimer's disease. In addition, enzyme kinetics study and molecular docking were conducted to establish the inhibition type and structure activity relationship.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom